Biochemical pathways mediated by KLK6 protease in breast cancer
Kallikrein‐related peptidase 6 (KLK6) is a serine protease normally expressed in mammary tissue and aberrantly regulated in breast cancer. At physiological levels, KLK6 functions as a suppressor of breast cancer, while its aberrant overexpression (> 50‐fold higher than normal) is characteristic o...
Saved in:
| Main Authors: | Georgios Pampalakis, Eleni Zingkou, Konstantinos Gus Sidiropoulos, Eleftherios P. Diamandis, Vassilis Zoumpourlis, George M. Yousef, Georgia Sotiropoulou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-11-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.12493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Significance of KLK7 expression, polymorphisms, and function in sheep horn growth
by: Mingzhu Shan, et al.
Published: (2025-01-01) -
Gastrodin attenuates diabetic cardiomyopathy characterized by myocardial fibrosis by inhibiting the KLK8-PAR1 signaling axis
by: MingShan Zhang, et al.
Published: (2024-11-01) -
Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy
by: Ketki Patil, et al.
Published: (2024-12-01) -
Characteristics and multi-omics analysis of spontaneous spondyloarthritis in non-human primates: Case report
by: Lei Cai, et al.
Published: (2025-01-01) -
S100A4 contributes to colorectal carcinoma aggressive behavior and to chemoradiotherapy resistance in locally advanced rectal carcinoma
by: Yohei Harada, et al.
Published: (2024-12-01)